Concordant with these findings, a recent study reported that hepatic MALAT1 expression was higher in NASH patients when compared to NAFLD patients with simple steatosis and controls [88]. This evidence concerns the gene MALAT1 and metabolic dysfunction-associated steatohepatitis.